Tom Malley

Insider profile

Currently holds positions in Kura Oncology Inc, Kiniksa Pharmaceuticals Ltd and BeOne Medicines AG

Performance

Overall performance
1.3

Performance over holding periods
1.3
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Kura Oncology Inc Oct. 14, 2015 -
Independent Director Kiniksa Pharmaceuticals Ltd Dec. 1, 2016 -
Non-Executive Independent Director BeOne Medicines AG Jan. 25, 2016 -
Independent Director Puma Biotechnology Inc Oct. 4, 2011 - Sept. 11, 2015

Tom Malley's trades of Kiniksa Pharmaceuticals Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
189.69
Quantity 40,805
Value US$864,935
Transaction date
Proposed sale
Price
33.32
Quantity 50,129
Value US$1,670,468
Transaction date
Proposed sale
Price
32.40
Quantity 49,407
Value US$1,600,641
Transaction date
Purchase
Price
11.50
Quantity 50,000 +55.8%
Value US$575,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-14 2025-08-14 PrS Proposed sale
40,805
189.69
US$864,935
40,805 189.69 US$864,935
2025-08-14 2025-08-14 S Sale
13,850 +16.6%
254.98
US$1,512,554
13,850 +16.6% 254.98 US$1,512,554
2025-08-14 2025-08-13 S Sale
32,767 +1.9%
481.26
US$2,266,942
32,767 +1.9% 481.26 US$2,266,942
2025-08-13 2025-08-13 PrS Proposed sale
50,129
33.32
US$1,670,468
50,129 33.32 US$1,670,468
2025-08-14 2025-08-12 S Sale
49,407 -79.7%
32.40
US$1,600,787
49,407 -79.7% 32.40 US$1,600,787
2025-08-12 2025-08-12 PrS Proposed sale
49,407
32.40
US$1,600,641
49,407 32.40 US$1,600,641
2023-06-21 2023-06-16 B Purchase
50,000 +55.8%
11.50
US$575,000
50,000 +55.8% 11.50 US$575,000